Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irradiated Donor Lymphocytes for Metastatic Renal Cell Carcinoma
NCT00176501Phase 2Terminated
- Sponsor
- Rutgers University
- Start
- Aug 2004
- Primary completion
- Aug 2008
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of donor lymphocyte infusion in renal cell carcinoma (RCC), sponsored by Rutgers University. Primary endpoint: Response Rate at 5 years. Started Aug 2004; status: terminated.
02
Drugs
donor lymphocyte infusion
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00176501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176501.